Literature DB >> 7642632

Characterization of the interleukin-4 nuclear activated factor/STAT and its activation independent of the insulin receptor substrate proteins.

H Kotanides1, M Moczygemba, M F White, N C Reich.   

Abstract

The activation of a latent DNA binding factor by interleukin-4 (IL-4), the IL-4 nuclear activated factor (IL-4 NAF), occurs within minutes of IL-4 binding to its receptor. Molecular characterization of IL-4NAF by ultraviolet light cross-linking experiments revealed a single protein of 120-130 kDa in contact with the DNA target site. Glycerol gradient sedimentation analysis indicated a molecular mass of IL-4 NAF consistent with a monomer that is capable of binding DNA. The IL-4 NAF target site is a palindromic sequence that is also recognized by the interferon-induced transcription factor, p91/STAT1 alpha. However, IL-4 NAF and p91/STAT1 alpha display distinguishable DNA binding specificities that may generate one level of specificity in the expression of target genes. Previous studies suggested the involvement of the insulin receptor substrate-1 (IRS-1) in the IL-4 signal transduction pathway. Although IRS-1 is involved in the stimulation of mitogenesis, our results demonstrate that activation of IL-4 NAF is independent of IRS-signaling proteins. The results of this study indicate that IL-4 stimulates bifurcating signal pathways that can direct mitogenesis via the IRS-signaling proteins and specific gene expression via the IL-4 NAF.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7642632     DOI: 10.1074/jbc.270.33.19481

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Rac1 mediates STAT3 activation by autocrine IL-6.

Authors:  T R Faruqi; D Gomez; X R Bustelo; D Bar-Sagi; N C Reich
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

2.  The interferon stimulated gene 54 promotes apoptosis.

Authors:  Marcin Stawowczyk; Sarah Van Scoy; K Prasanna Kumar; Nancy C Reich
Journal:  J Biol Chem       Date:  2010-12-29       Impact factor: 5.157

3.  Regulated nuclear import of the STAT1 transcription factor by direct binding of importin-alpha.

Authors:  Kevin M McBride; Gregg Banninger; Christine McDonald; Nancy C Reich
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

4.  Live cell imaging reveals continuous STAT6 nuclear trafficking.

Authors:  Hui-Chen Chen; Nancy C Reich
Journal:  J Immunol       Date:  2010-05-24       Impact factor: 5.422

5.  Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling.

Authors:  Yi Zeng; Xunhai Zhang; Zan Huang; Lin Cheng; Shuihong Yao; Di Qin; Xiuying Chen; Qiao Tang; Zhigang Lv; Ling Zhang; Chun Lu
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

6.  Requirements for interleukin-4-induced gene expression and functional characterization of Stat6.

Authors:  T Mikita; D Campbell; P Wu; K Williamson; U Schindler
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

7.  STAT6 mediates interleukin-4 growth inhibition in human breast cancer cells.

Authors:  Jennifer L Gooch; Barbara Christy; Douglas Yee
Journal:  Neoplasia       Date:  2002 Jul-Aug       Impact factor: 5.715

8.  The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway.

Authors:  Jong-In Park; Christopher J Strock; Douglas W Ball; Barry D Nelkin
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

9.  Antigen-specific signaling by a soluble, dimeric peptide/major histocompatibility complex class II/Fc chimera leading to T helper cell type 2 differentiation.

Authors:  S Casares; C S Zong; D L Radu; A Miller; C A Bona; T D Brumeanu
Journal:  J Exp Med       Date:  1999-08-16       Impact factor: 14.307

10.  The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB.

Authors:  H L Pahl; B Krauss; K Schulze-Osthoff; T Decker; E B Traenckner; M Vogt; C Myers; T Parks; P Warring; A Mühlbacher; A P Czernilofsky; P A Baeuerle
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.